Drugs & Supplements
advertisement
What do you feel about the cost of the medicine? Is it expensive or reasonable?

Medication: Alnavas

Alnavas

Pharmacological action

Alnavas is a lipid-lowering drugs of the statin group. An inhibition of HMG-CoA reductase leads to a series of sequential reactions that result in reduced intracellular cholesterol content and it is a compensatory increase in activity of LDL receptors and thus accelerate the catabolism of LDL cholesterol.

The lipid-lowering effect of statins is associated with lower levels of total cholesterol by LDL-C. The reduction in LDL cholesterol is dose-dependent and is not linear, but exponential. The inhibitory effect of Alnavas on HMG-CoA reductase by about 70% determined by the activity of its circulating metabolites.

Statins do not affect the activity of lipoprotein lipase and hepatic, no significant effect on the synthesis and catabolism of free fatty acids, so their effect on triglycerides and again vicariously through their main effects on reducing LDL-C.

In addition to lipid-lowering actions, statins have beneficial effects in endothelial dysfunction (pre-clinical sign of early atherosclerosis) in the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties.

Alnavas lowers cholesterol levels in patients with homozygous familial hypercholesterolemia, which is usually not amenable to therapy with lipid-lowering agents.

Pharmacokinetics

Alnavas is rapidly absorbed from the gastrointestinal tract. The absolute bioavailability is low (about 12%) due to first-pass clearance in gastrointestinal mucosa and / or due to the "first pass" through the liver, predominantly in the scene. Alnavas is metabolized with the participation of isoenzyme CYP3A4 to form a number of substances which are inhibitors of HMG-CoA reductase inhibitors.

T1/2 from plasma is about 14 hours, although the T1/2 inhibitor activity of HMG-CoA reductase is approximately 20-30 hours, due to the involvement of active metabolites.

The plasma protein binding is 98%.

Alnavas is excreted in the form of metabolites mainly in the bile.

Why is Alnavas prescribed?

Primary hypercholesterolemia in ineffectiveness of diet, combined hypercholesterolemia and hypertriglyceridemia, heterozygous and homozygous familial hypercholesterolemia with the ineffectiveness of diet.

Dosage and administration

The treatment by Alnavas is with a standard diet for patients with hypercholesterolemia. The dose is determined individually, depending on the initial cholesterol levels. This medication is taken orally. The initial dose is usually 10 mg 1 time / day. The effect is manifested within 2 weeks, and the maximum effect is for 4 weeks. If necessary, the dose can be gradually increased every 4 weeks or more. The maximum daily dose is 80 mg.

Alnavas side effects, adverse reactions

Digestive system: constipation, flatulence, dyspepsia, abdominal pain, nausea, diarrhea.

CNS and peripheral nervous system: headache, insomnia.

Other: asthenia, myalgia.

Alnavas contraindications

Liver disease in the active phase, increasing the serum transaminase activity more than 3 times of unknown origin, pregnancy, lactation (breastfeeding), hypersensitivity to atorvastatin. Women of reproductive age not using reliable contraception.

Using during pregnancy and breastfeeding

Alnavas is contraindicated during pregnancy and lactation (breastfeeding).

It is not known whether Alnavas is allocated in breast milk. Given the potential for adverse effects in infants, if necessary to use this drug during lactation it should decide on the termination of breastfeeding.

Women of reproductive age during treatment should use adequate contraceptive methods. Alnavas may be used in women of childbearing age only if the probability of pregnancy is very low, and the patient informed about the possible risk of treatment for the fetus.

Category of the fetus by FDA - X.

Special instructions

Prior to and during treatment with atorvastatin, especially if symptoms of liver damage, it is necessary to monitor liver function tests. With an increase in transaminase levels it should be monitored their activity up to normalization. If AST or ALT more than 3 times the norm persists, we recommend reducing the dose or withdrawal of atorvastatin.

When prompted during the treatment of symptoms of myopathy it should determine the activity of creatine kinase. If a significant increase in CK levels is preserved, it is recommended to reduce the dose of Alnavas or to cancel taking it.

The risk of myopathy during the treatment with Alnavas increased, while the use of cyclosporine, fibrates, erythromycin, antifungal agents belonging to azoles, and niacin.

There is a likelihood of the following side effects, but not in all cases, a clear link with taking atorvastatin: muscle cramps, myositis, myopathy, paresthesia, peripheral neuropathy, pancreatitis, hepatitis, cholestatic jaundice, anorexia, vomiting, alopecia, pruritus, rash, impotence, hyperglycemia and hypoglycemia.

The children experience of Alnavas using at a dose of 80 mg / day is restricted.

With careful use Alnavas in patients with chronic alcoholism.

Alnavas drug interactions

When this drug applied simultaneously with:

- digoxin slightly increased concentration of digoxin in plasma.

- itraconazole greatly increases the concentration of Alnavas in plasma, apparently due to inhibition of itraconazole its metabolism in the liver that occurs with the participation of isoenzyme CYP3A4; increased risk of myopathy.

- colestipol may decrease the concentration of Alnavas in plasma, with lipid-lowering effect is enhanced.

- antacids containing magnesium hydroxide and aluminum hydroxide, reduce the concentration of Alnavas by approximately 35%.

- cyclosporine, fibrates (including gemfibrozil), azole antifungals derivatives, nicotinic acid increases the risk of myopathy.

- erythromycin, clarithromycin moderately increased concentrations of Alnavas in plasma, increases the risk of myopathy.

- ethinyl estradiol, norethisterone (norethindrone) slightly increases the concentration of ethinyl estradiol, norethisterone and (norethindrone) in blood plasma.

- protease inhibitors increases the concentration of Alnavas in plasma, as protease inhibitors are inhibitors of the CYP3A4 isoenzyme.

Diltiazem, verapamil, isradipine inhibit isoenzyme CYP3A4, which participates in the metabolism of Alnavas Sanis Health, so that while the use of these calcium channel blockers may increase the concentration of Alnavas in plasma and increased risk of myopathy.

Alnavas in case of emergency / overdose

Treatment: symptomatic and supportive therapy. There is no specific antidote. Hemodialysis is ineffective.

advertisement

Alnavas pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products:

infoActive ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug. The below information contains the active ingredients of Alnavas drug.


Alnavas available forms, composition, doses:

infoForm of the drug is the form in which the drug is marketed in the market, for example, a drug x can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same drug can be available as injection form. Each drug cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a drug. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the drug stable.
Doses are various strengths of the drug like 10mg, 20mg, 30mg and so on. Each drug comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease. The below information contains the forms, composition, doses of Alnavas drug.


Alnavas destination | category:

infoDestination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so. The below information contains the destination, category of Alnavas drug.


Alnavas indications and usages, anatomical therapeutic chemical and diseases classification codes:

infoA drug is classified depending on the organ or system it acts[Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the drug. A drug can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code. The below information contains the Indications and usages, anatomical therapeutic chemical and diseases classification codes of Alnavas drug.


Alnavas pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers:

infoPharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug. The below information contains the information about Pharmaceutical companies and Researchers involved in the development of Alnavas drug.


advertisement

Alnavas - Frequently asked Questions

Can i drive or operate heavy machine after consuming Alnavas?

Depending on the reaction of the Alnavas after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Alnavas not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Alnavas addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

Visitor reports

Medicatione.com conducted a study on Alnavas, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Alnavas consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reported useful

No survey data has been collected yet


Visitor reported side effects

No survey data has been collected yet


Visitor reported price estimates

No survey data has been collected yet


Visitor reported frequency of use

No survey data has been collected yet


Visitor reported doses

No survey data has been collected yet


Visitor reported time for results

No survey data has been collected yet


Visitor reported administration

No survey data has been collected yet


Visitor reported age

No survey data has been collected yet


Reviews:


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  <= Write 23 here

 

 

About    |    
© 2002 - 2017 "Medicatione.com". All Rights Reserved